Ferring Pharmaceuticals R&D lab to come up in Hyderabad

Image
Press Trust of India Hyderabad
Last Updated : Jun 30 2018 | 9:40 PM IST

Ferring Pharmaceuticals, a pharma major from Europe, laid the foundation stone for their state- of-the art R&D laboratory and manufacturing facility here today.

The event was attended by Telangana Industries Minister KT Rama Rao and several other dignitaries, a state government release said.

Ferring Pharmaceuticals is a Switzerland-based Euro 2 billion research-driven specialty biopharmaceutical group and a leader in reproductive medicine and womens health. It has a strong presence in specialty areas within gastroenterology and urology, it said.

Ferring established its Indian subsidiary in 1997 and has thus far established a manufacturing facility, an R&D centre and commercial operations in Maharashtra, it said.

"The new facility will also add to group's global R&D capabilities and will cater to building a pool of novel research for emerging healthcare challenges around the world.

Ferring plans to complete the project in three phases with a total proposed investment of USD 250 million, with an estimated INR 235 crore into the first phase itself," the release said.

Welcoming Ferring to Genome Valley, a life sciences cluster here, Rao said the government is "delighted to have Ferring Pharma join the impressive list of companies who are present in this cluster".

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Jun 30 2018 | 9:40 PM IST

Next Story